LENZ Therapeutics, Inc. Common Stock
$4.07
-$0.06 (-1.45%)
$4.04Day Range$4.14
Key Statistics
Market Cap
$129.77M
Shares Outstanding
31.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Mar 22, 2024
Round Lot
100
Locale
US
Trading Data
Day Open
$4.10
Day High
$4.14
Day Low
$4.04
Volume
735.2K
VWAP
$4.08
Prev Close
$4.13
Transactions
--
Acc. Volume
--
About LENZ Therapeutics, Inc. Common Stock
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 2836152 employees201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075858-925-7000IPO Mar 22, 2024US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001815776
- Composite FIGI
- BBG00XDH4NZ2
- Share Class FIGI
- BBG00XDH4P05
- Ticker Root
- LENZ
- SIC Code
- 2836
About LENZ Therapeutics, Inc. Common Stock (LENZ) Stock
LENZ Therapeutics, Inc. Common Stock (LENZ) closed the 2026-09-18 session at $4.07, down 1.45% versus the previous close (-0.06). The stock opened at $4.10 and traded between $4.04 and $4.14 during that session. Session trading volume was 735K shares. The volume-weighted average price (VWAP) is $4.08.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products. Its products VIZZ (aceclidine ophthalmic solution) 1.44% is a once-daily eye drop developed to restore clear near vision for up to 10 hours. VIZZ is powered by aceclidine, highlighted by its differentiated mechanism of action as a predominantly pupil-selective miotic that interacts with the iris, with minimal ciliary muscle stimulation.
LENZ Therapeutics, Inc. Common Stock has a market capitalization of $129.8 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. LENZ is listed on the XNAS exchange. The company employs approximately 152 people. LENZ Therapeutics, Inc. Common Stock is headquartered in SOLANA BEACH, CA. The recorded listing date is 2024-03-22.
On this page you can find market LENZ stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.